bifido

ADDRESS 23-16, Nonggongdanji-gil, Hongcheon-eup, Hongcheon-gun, Gangwon-do, Republic of Korea
TEL + 82-33-435-4962
FAX + 82-33-435-4963
Email bgn4@bifido.com
Category
ADDRESS Room 916, Blue zone,150, Jojeong-daero, Hanam-si, Gyeonggi-do, Republic of Korea
TEL + 82-31-8027-8941
FAX + 82-31-8027-8946
Email bgn4@bifido.com
Category
ADDRESS 3rd floor, 639, Seolleung-ro, Gangnam-gu, Seoul, Republic of Korea
TEL + 82-2-543-5196
FAX + 82-70-7545-0189
Email bgn4@bifido.com
Category
ADDRESS Room 1005, Building No.1, No.7001 Zhongchun Road, MinhangDistrict, 201101 Shanghai China
TEL +86-21-54718163
Email bgn4@bifido.com
Category

Investors

Accrued Bioinformatics
Through Decades

공시정보
목록

공시제목 제출일자
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(높은 EPS 분비능을 보이는 와이셀라 컨푸사 VP30 및 이로부터 발효된 발효물을 포함하는 변비 개선용 식품 조성물) 2021-10-06
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(비피도박테리움 롱검 RAPO(KTCT13773BP)를 포함하는 암 예방 또는 치료용 조성물) 2021-09-27
Change of The Largest Shareholder 2021-09-14
[Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder 2021-09-14
Change of CEO 2021-09-14
Outcomes of Extraordinary General Meeting of Shareholders 2021-09-14
[Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder 2021-09-10
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(류마티스관절염 개선, 예방 또는 치료를 위한 비피도박테리움 롱검 RAPO 균주 및 이를 포함하는 조성물) 2021-09-02
[Revised]Resolutions for Convocation of General Meeting of Shareholders 2021-08-30
Resolutions for Convocation of General Meeting of Shareholders 2021-08-04
[Revised]Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder 2021-07-23
Contract of Shares Acquisition and Assignment accompanied with the change of the largest shareholder 2021-07-21
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(부티릴 프락토올리고당을 포함하는 프리바이오틱스 조성물) 2021-06-16
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(류마티스관절염 개선, 예방 또는 치료를 위한 락토바실러스 가세리 HHuMin-R 균주 및 이를 포함하는 조성물) 2021-06-08
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(류마티스 관절염 개선, 예방 또는 치료를 위한 비피도박테리움 슈도카테눌라툼 C-RAPO 균주 및 이를 포함하는 조성물) 2021-06-07
Other Management Information(Obtainment of Patent)(Voluntary Disclosure)(비피도박테리움 비피덤을 이용한 인간 EGF 단백질의 생산방법 및 이를 함유하는 조성물) 2021-05-13
Additional Listing(무상증자) 2021-04-20
Ex-Rights(무상증자) 2021-03-31
Outcomes of Annual Meeting of Shareholders 2021-03-26
Submission of Audit Report 2021-03-18
top으로 이동